Clinical impact of primary tumour 123ImIBG response to induction chemotherapy in children with high-risk neuroblastoma
{{output}}
Background: More than 50% children with high-risk neuroblastoma (HR-NBL) experience disease progression, which we hypothesise is due to non-response of primary tumour to treatment. Current imaging techniques are unable to charact... ...
